JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, C. Y.
Right arrow Articles by Halushka, P. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, C. Y.
Right arrow Articles by Halushka, P. V.

The effects of alpha adrenergic agents on human platelet aggregation

CY Hsu, DR Knapp and PV Halushka

The effects of alpha adrenergic agonists and antagonists on human in vitro platelet aggregation were studied to characterize further the platelet alpha adrenergic receptor. Aggregation induced by ADP and U46619; a stable prostaglandin endoperoxide analog, was potentiated by alpha adrenergic agonists, an effect which was completely blocked by the alpha adrenergic antagonist phentolamine (1 X 10(-6) M) but not by prazosin (1 X 10(-6) M). The order of potency for the alpha adrenergic agonists in potentiating ADP-induced aggregation was clonidine greater than or equal to epinephrine greater than alpha-methylnorepinephrine greater than norepinephrine greater than phenylephrine greater than methoxamine. Epinephrine-induced platelet aggregation was blocked by phentolamine, yohimbine, dihydroergotamine, clonidine and lofexidine but not by phenoxybenzamine (1 X 10(-5) M). These findings suggest that: 1)clonidine and lofexidine are partial agonists and 2) that the alpha adrenergic receptor of the platelet is different from the classical postsynaptic alpha adrenergic receptor and more closely resembles presynaptic alpha adrenergic receptors.

Volume 208, Issue 3, pp. 366-370, 03/01/1979
Copyright © 1979 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Yang, J. Wu, M. A. Kowalska, A. Dalvi, N. Prevost, P. J. O'Brien, D. Manning, M. Poncz, I. Lucki, J. A. Blendy, et al.
Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs
PNAS, August 17, 2000; (2000) 180194597.
[Abstract] [Full Text]

Home page
 BloodHome page
M. A. Kowalska, M. Z. Ratajczak, M. Majka, J. Jin, S. Kunapuli, L. Brass, and M. Poncz
Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets
Blood, July 1, 2000; 96(1): 50 - 57.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Lin and D. B. Young
Opposing Effects of Plasma Epinephrine and Norepinephrine on Coronary Thrombosis In Vivo
Circulation, February 15, 1995; 91(4): 1135 - 1142.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Yang, J. Wu, M. A. Kowalska, A. Dalvi, N. Prevost, P. J. O'Brien, D. Manning, M. Poncz, I. Lucki, J. A. Blendy, et al.
Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs
PNAS, August 29, 2000; 97(18): 9984 - 9989.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics.